ArticleAmerican journal of translational research2026
Correlation between ocular tumor distribution and age based on analysis of pathological specimens.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the distribution of benign and malignant eyelid tumors and their relationship with age, and to provide a reference for clinical diagnosis and treatment.
methodsA retrospective review was conducted on 1,056 patients with eyelid tumors. Clinicopathological data were collected to evaluate the histopathological characteristics and anatomical site distribution of the tumors. The association between age and the distribution of benign and malignant eyelid tumors was analyzed.
resultsAmong the 1,056 patients with eyelid tumors, 754 (71.40%) cases were benign, whereas 302 (28.60%) cases were malignant. The upper eyelid was the most affected site (44.03%), followed by lower eyelid (41.95%). In patients aged 0-19 years, all tumors were benign. The proportion of malignant tumors increased with age and reached 45.21% in those aged ≥80 years (χ
conclusionThe type and malignancy of eyelid tumors are closely related to age, gender, and tumor location, while the depth of malignant tumor infiltration is associated with age and anatomical site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.